Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Clinical trial NCT00066690 · COMPLETED

Trial details

NCT number: NCT00066690
Sponsor: ETOP IBCSG Partners Foundation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Estrogen Receptor Positive Breast Cancer Progesterone Receptor Positive Tumor Recurrent Breast Carcinoma Stage IA Breast Cancer Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer

Start date: 2003-12-17
Primary completion: 2014-05-01
Enrollment: 3066

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.